-
Study aim
-
Evaluation of the effect of transcranial direct current stimulation, olfactory stimulation and their combination in intensive care unit (ICU) patients with disorder of consciousness (DOC)
-
Design
-
A controlled, parallel-group, double-blind, randomized, phase 3 clinical trial on 60 patients. A computer randomization sequence was used for randomization.
-
Settings and conduct
-
This study is conducted as a clinical trial on the patients of the intensive care unit with disorder of consciousness referred to Loghman Hakim Hospital. Patients who meet the inclusion criteria are randomly assigned to one of three groups. The data will be coded and without the patient's name and grouping, and in sealed envelopes, will be provided to the person analyzing the data.The patient and the person evaluating the data are blind.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria included age ≥ 18 years, brain injuries, non-hemorrhagic stroke, Glasgow Coma Scale greater than 9, 7. Patients without tracheostomy, and exclusion criteria included complications reducing brain function, referral to other centers, and patient death.
-
Intervention groups
-
In the transcranial direct current stimulation (tDCS) group, participants will receive tDCS daily for five consecutive days in 20-minute sessions targeting areas of the brain involved in consciousness, such as the left dorsolateral prefrontal cortex (DLPFC).In the olfactory stimulation group, the participants are subjected to olfactory stimulation for 15 minutes, twice a day, for a period of five days, using unpleasant scents and the stimulant pyridine. In the combination group, participants will receive both tDCS and olfactory stimulation.
-
Main outcome variables
-
Glasgow Coma Scale; quantitative electroencephalography; length of stay in ICU; Complications of hospitalization in ICU; Prognosis, tDCS stimulation; olfactory stimulation